Biosynthesis, Deficiency, and Supplementation of Coenzyme Q
暂无分享,去创建一个
G. Brea-Calvo | I. Hargreaves | D. Mantle | L. García-Corzo | Nadia Turton | L. Millichap | Carmine Staiano | Laura García-Corzo
[1] E. Bonora,et al. Mutant SPART causes defects in mitochondrial protein import and bioenergetics reversed by Coenzyme Q , 2023, Open Biology.
[2] G. López-Lluch,et al. Coenzyme Q10 Metabolism: A Review of Unresolved Issues , 2023, International journal of molecular sciences.
[3] T. Langer,et al. Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7 , 2023, Nature Cell Biology.
[4] D. Pagliarini,et al. Coenzyme Q biochemistry and biosynthesis. , 2023, Trends in biochemical sciences.
[5] I. Hargreaves,et al. Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders. , 2022, Frontiers in bioscience.
[6] E. Emekli-Alturfan,et al. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence , 2022, Molecular Biology Reports.
[7] D. Timmann,et al. Bi‐Allelic COQ4 Variants Cause Adult‐Onset Ataxia‐Spasticity Spectrum Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.
[8] A. Heck,et al. The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency , 2022, Redox biology.
[9] P. Meikle,et al. High-intensity training induces non-stoichiometric changes in the mitochondrial proteome of human skeletal muscle without reorganisation of respiratory chain content , 2021, Nature Communications.
[10] J. Coon,et al. Structure and functionality of a multimeric human COQ7:COQ9 complex , 2021, bioRxiv.
[11] G. Vasco,et al. Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes , 2021, Journal of Medical Genetics.
[12] Robert S. Banh,et al. The polar oxy-metabolome reveals the 4-hydroxymandelate CoQ10 synthesis pathway , 2021, Nature.
[13] J. Kallijärvi,et al. The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology , 2021, The FEBS journal.
[14] C. Clarke,et al. Coenzyme Q Biosynthesis: An Update on the Origins of the Benzenoid Ring and Discovery of New Ring Precursors , 2021, Metabolites.
[15] G. López-Lluch,et al. Secondary CoQ10 deficiency, bioenergetics unbalance in disease and aging , 2021, BioFactors.
[16] A. Tessa,et al. New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts , 2021, Journal of Neurology.
[17] E. Trevisson,et al. Primary coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations. , 2021, Free radical biology & medicine.
[18] G. Lenaers,et al. Secondary coenzyme q deficiency in neurological disorders. , 2021, Free radical biology & medicine.
[19] V. Carelli,et al. Missense PDSS1 mutations in CoenzymeQ10 synthesis cause optic atrophy and sensorineural deafness , 2020, Annals of clinical and translational neurology.
[20] Timothy E. Yap,et al. Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain , 2020, International journal of molecular sciences.
[21] S. Heales,et al. CoQ10 Deficient Endothelial Cell Culture Model for the Investigation of CoQ10 Blood–Brain Barrier Transport , 2020, Journal of clinical medicine.
[22] I. Hargreaves,et al. Disorders of Human Coenzyme Q10 Metabolism: An Overview , 2020, International journal of molecular sciences.
[23] M. Mroczek,et al. Adult‐onset very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) , 2020, European journal of neurology.
[24] E. Bouveret,et al. The O2-independent pathway of ubiquinone biosynthesis is essential for denitrification in Pseudomonas aeruginosa , 2020, The Journal of Biological Chemistry.
[25] Min Goo Lee,et al. ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment. , 2020, Journal of the American Society of Nephrology : JASN.
[26] C. Quinzii,et al. Redefining infantile-onset multisystem phenotypes of coenzyme Q10-deficiency in the next-generation sequencing era , 2020, Journal of translational genetics and genomics.
[27] J. Hicks,et al. An in situ atlas of mitochondrial DNA in mammalian tissues reveals high content in stem/progenitor cells. , 2020, The American journal of pathology.
[28] O. Shirihai,et al. COQ11 deletion mitigates respiratory deficiency caused by mutations in the gene encoding the coenzyme Q chaperone protein Coq10 , 2020, The Journal of Biological Chemistry.
[29] H. Yen,et al. Characterization of human mitochondrial PDSS and COQ proteins and their roles in maintaining coenzyme Q10 levels and each other's stability. , 2020, Biochimica et biophysica acta. Bioenergetics.
[30] A. Olgaç,et al. A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation , 2019, Journal of pediatric endocrinology & metabolism : JPEM.
[31] S. Hekimi,et al. The Complexity of Making Ubiquinone , 2019, Trends in Endocrinology & Metabolism.
[32] J. Olzmann,et al. The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.
[33] A. Konnerth,et al. Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity , 2019, Nature Neuroscience.
[34] P. Navas,et al. Vanillic Acid Restores Coenzyme Q Biosynthesis and ATP Production in Human Cells Lacking COQ6 , 2019, Oxidative medicine and cellular longevity.
[35] M. Fontecave,et al. Ubiquinone Biosynthesis over the Entire O2 Range: Characterization of a Conserved O2-Independent Pathway , 2019, mBio.
[36] Jun Z. Li,et al. COQ4 Mutation Leads to Childhood-Onset Ataxia Improved by CoQ10 Administration , 2019, The Cerebellum.
[37] M. Gallagher-Jones,et al. Human COQ10A and COQ10B are distinct lipid-binding START domain proteins required for coenzyme Q function[S] , 2019, Journal of Lipid Research.
[38] M. Fontecave,et al. A Soluble Metabolon Synthesizes the Isoprenoid Lipid Ubiquinone. , 2019, Cell chemical biology.
[39] L. Ulatowski,et al. Vitamin E: Mechanism of transport and regulation in the CNS , 2019, IUBMB life.
[40] F. Hildebrandt,et al. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice. , 2019, Journal of the American Society of Nephrology : JASN.
[41] J. Coon,et al. Coenzyme Q biosynthetic proteins assemble in a substrate-dependent manner into domains at ER–mitochondria contacts , 2019, The Journal of cell biology.
[42] M. Schuldiner,et al. The Endoplasmic Reticulum-Mitochondria Encounter Structure Complex Coordinates Coenzyme Q Biosynthesis , 2019, Contact (Thousand Oaks (Ventura County, Calif.)).
[43] J. Duarte,et al. β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9 R239X mice , 2018, EMBO molecular medicine.
[44] R. Peters,et al. Isoprenyl diphosphate synthases: the chain length determining step in terpene biosynthesis , 2018, Planta.
[45] A. Mégarbané,et al. COQ8A and MED25 Mutations in a Child with Intellectual Disability, Microcephaly, Seizures, and Spastic Ataxia: Synergistic Effect of Digenic Variants , 2018, Molecular Syndromology.
[46] M. Donnino,et al. Coenzyme Q10 in acute influenza , 2018, Influenza and other respiratory viruses.
[47] R. Rodenburg,et al. Coenzyme Q10 deficiency due to a COQ4 gene defect causes childhood-onset spinocerebellar ataxia and stroke-like episodes , 2018, Molecular genetics and metabolism reports.
[48] E. Trevisson,et al. Clinical syndromes associated with Coenzyme Q10 deficiency. , 2018, Essays in biochemistry.
[49] C. Clarke,et al. Coenzyme Q10 deficiencies: pathways in yeast and humans , 2018, Essays in biochemistry.
[50] Carol E Smith,et al. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose , 2018, BMC Cardiovascular Disorders.
[51] Kitti Brinyiczki,et al. Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency , 2018, Pediatric Nephrology.
[52] Sean J. Humphrey,et al. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance , 2018, eLife.
[53] Robert W. Taylor,et al. A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C‐methyltransferase deficiency , 2018, Human mutation.
[54] Christopher P. Lapointe,et al. Multi-omics Reveal Specific Targets of the RNA-Binding Protein Puf3p and Its Orchestration of Mitochondrial Biogenesis. , 2017, Cell systems.
[55] Nicholas W. Kwiecien,et al. Multi-omic mitoprotease profiling defines a role for Oct1p in coenzyme Q production , 2017, bioRxiv.
[56] L. C. López,et al. Bypassing human CoQ10 deficiency. , 2017, Molecular genetics and metabolism.
[57] Paul D Hutchins,et al. Conserved Lipid and Small-Molecule Modulation of COQ8 Reveals Regulation of the Ancient Kinase-like UbiB Family. , 2017, Cell chemical biology.
[58] I. Atanassov,et al. Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals , 2017, eLife.
[59] F. Wang,et al. Steroid-resistant nephrotic syndrome caused by co-inheritance of mutations at NPHS1 and ADCK4 genes in two Chinese siblings. , 2017, Intractable & rare diseases research.
[60] R. Rodenburg,et al. 4‐Hydroxybenzoic acid restores CoQ10 biosynthesis in human COQ2 deficiency , 2017, Annals of clinical and translational neurology.
[61] D. Pagliarini,et al. Biochemistry of Mitochondrial Coenzyme Q Biosynthesis. , 2017, Trends in biochemical sciences.
[62] R. de Cabo,et al. Kaempferol increases levels of coenzyme Q in kidney cells and serves as a biosynthetic ring precursor , 2017, Free radical biology & medicine.
[63] M. Accetturo,et al. Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants , 2017, Clinical genetics.
[64] K. Moon,et al. COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[65] F. Pierrel. Impact of Chemical Analogs of 4-Hydroxybenzoic Acid on Coenzyme Q Biosynthesis: From Inhibition to Bypass of Coenzyme Q Deficiency , 2017, Front. Physiol..
[66] N. Sondheimer,et al. Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ10 deficiency , 2017, Molecular genetics and metabolism reports.
[67] Aneal Khan,et al. Pathogenicity of two COQ7 mutations and responses to 2,4‐dihydroxybenzoate bypass treatment , 2017, Journal of cellular and molecular medicine.
[68] A. Elmacı,et al. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment , 2017, Pediatric Nephrology.
[69] J. Sánchez-Alcázar,et al. Amitriptyline down‐regulates coenzyme Q10 biosynthesis in lung cancer cells , 2017, European journal of pharmacology.
[70] Nicola Zamboni,et al. An integrative metabolomics and transcriptomics study to identify metabolic alterations in aged skin of humans in vivo , 2017, BMC Genomics.
[71] D. Torres-Russotto,et al. A novel CABC1/ADCK3 mutation in adult-onset cerebellar ataxia. , 2016, Parkinsonism & related disorders.
[72] P. Navas,et al. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. , 2016, Mitochondrion.
[73] D. Schneider,et al. Evolution of Ubiquinone Biosynthesis: Multiple Proteobacterial Enzymes with Various Regioselectivities To Catalyze Three Contiguous Aromatic Hydroxylation Reactions , 2016, mSystems.
[74] S. Johansson,et al. ADCK3 mutations with epilepsy, stroke‐like episodes and ataxia: a POLG mimic? , 2016, European journal of neurology.
[75] M. Moscovich,et al. Statin-associated cerebellar ataxia. A Brazilian case series. , 2016, Parkinsonism & related disorders.
[76] M. Kawamukai. Biosynthesis of coenzyme Q in eukaryotes , 2016, Bioscience, biotechnology, and biochemistry.
[77] S. Crovella,et al. Alendronate, a double-edged sword acting in the mevalonate pathway , 2015, Molecular medicine reports.
[78] T. Meitinger,et al. Fatal neonatal encephalopathy and lactic acidosis caused by a homozygous loss-of-function variant in COQ9 , 2015, European Journal of Human Genetics.
[79] A. Mourier,et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4–dihydroxybensoic acid , 2015, Journal of Medical Genetics.
[80] D. Acuña-Castroviejo,et al. The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene , 2015, EMBO molecular medicine.
[81] S. Hekimi,et al. Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis , 2015, Nature Communications.
[82] E. Bertini,et al. COQ4 Mutations Cause a Broad Spectrum of Mitochondrial Disorders Associated with CoQ10 Deficiency , 2015, American journal of human genetics.
[83] Crysten E. Blaby-Haas,et al. Identification of Coq11, a New Coenzyme Q Biosynthetic Protein in the CoQ-Synthome in Saccharomyces cerevisiae* , 2015, The Journal of Biological Chemistry.
[84] E. Trevisson,et al. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency , 2015, Journal of Inherited Metabolic Disease.
[85] Yuki Ogiyama,et al. Functional Conservation of Coenzyme Q Biosynthetic Genes among Yeasts, Plants, and Humans , 2014, PloS one.
[86] Christian G Elowsky,et al. The Origin and Biosynthesis of the Benzenoid Moiety of Ubiquinone (Coenzyme Q) in Arabidopsis[W] , 2014, Plant Cell.
[87] Stephanie D. Wilson,et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. , 2014, JAMA neurology.
[88] I. Hargreaves. Coenzyme Q10 as a therapy for mitochondrial disease. , 2014, The international journal of biochemistry & cell biology.
[89] M. Sikorska,et al. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease , 2014, BMC Neuroscience.
[90] G. Rimbach,et al. Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women. , 2014, The Journal of clinical endocrinology and metabolism.
[91] P. Navas,et al. Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency☆ , 2014, Biochimica et biophysica acta.
[92] S. Seneca,et al. Characterization of CoQ10 biosynthesis in fibroblasts of patients with primary and secondary CoQ10 deficiency , 2014, Journal of Inherited Metabolic Disease.
[93] V. Plagnol,et al. Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[94] S. Seneca,et al. Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[95] R. Artuch,et al. Coenzyme Q₁₀ deficiency in mitochondrial DNA depletion syndromes. , 2013, Mitochondrion.
[96] N. Gregersen,et al. Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency. , 2013, Human molecular genetics.
[97] Stefan Siebrecht,et al. Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study , 2013, Journal of the International Society of Sports Nutrition.
[98] D. Stainier,et al. Ubiad1 Is an Antioxidant Enzyme that Regulates eNOS Activity by CoQ10 Synthesis , 2013, Cell.
[99] F. Rosenfeldt,et al. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial , 2013, Cardiology journal.
[100] S. Rahman,et al. Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment , 2013, Journal of Inherited Metabolic Disease.
[101] S. Kelekçi,et al. The relationships between clinical outcome and the levels of total antioxidant capacity (TAC) and coenzyme Q (CoQ 10) in children with pandemic influenza (H 1 N1) and seasonal flu. , 2012, European review for medical and pharmacological sciences.
[102] S. Dimauro,et al. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. , 2012, Archives of neurology.
[103] M. Fontecave,et al. Overexpression of the Coq8 Kinase in Saccharomyces cerevisiae coq Null Mutants Allows for Accumulation of Diagnostic Intermediates of the Coenzyme Q6 Biosynthetic Pathway* , 2012, The Journal of Biological Chemistry.
[104] M. Cordero,et al. Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients. , 2012, Journal of psychiatric research.
[105] D. Selkoe,et al. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. , 2011, Archives of neurology.
[106] S. Dimauro,et al. Coenzyme Q deficiency in muscle. , 2011, Current opinion in neurology.
[107] M. Fontecave,et al. Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogs rescue Coq6 deficiency. , 2011, Chemistry & biology.
[108] I. Carrié,et al. Lifelong low-phylloquinone intake is associated with cognitive impairments in old rats. , 2011, The Journal of nutrition.
[109] N. Pfanner,et al. Mitochondrial protein turnover: role of the precursor intermediate peptidase Oct1 in protein stabilization , 2011, Molecular biology of the cell.
[110] V. Pertegato,et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. , 2011, The Journal of clinical investigation.
[111] W. Pavan,et al. Oxidative stress in Niemann-Pick disease, type C. , 2010, Molecular genetics and metabolism.
[112] M. Mikhail,et al. Effects of Oral, Vaginal, and Transdermal Hormonal Contraception on Serum Levels of Coenzyme Q10, Vitamin E, and Total Antioxidant Activity , 2010, Obstetrics and gynecology international.
[113] T. Douki,et al. Involvement of mitochondrial ferredoxin and para-aminobenzoic acid in yeast coenzyme Q biosynthesis. , 2010, Chemistry & biology.
[114] J. Berner. Statins can produce ataxia in bipolar disorder: two case reports. , 2010, The Journal of clinical psychiatry.
[115] M. Mancuso,et al. Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy , 2010, Neuromuscular Disorders.
[116] A. Verméglio,et al. Menaquinone as pool quinone in a purple bacterium , 2009, Proceedings of the National Academy of Sciences.
[117] A. Singleton,et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. , 2009, American journal of human genetics.
[118] P. Sleiman,et al. The coenzyme Q10 status of the brain regions of Parkinson’s disease patients , 2008, Neuroscience Letters.
[119] L. Salviati,et al. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. , 2008, The New England journal of medicine.
[120] A. Munnich,et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. , 2008, American journal of human genetics.
[121] E. Bertini,et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. , 2007, Journal of the American Society of Nephrology : JASN.
[122] H. Cavé,et al. Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency , 2007, Journal of Inherited Metabolic Disease.
[123] S. Dimauro,et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. , 2007, Brain : a journal of neurology.
[124] A. Munnich,et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. , 2007, The Journal of clinical investigation.
[125] Wayne R Matson,et al. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. , 2006, Biochimica et biophysica acta.
[126] M. Mikhail,et al. Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. , 2006, American journal of obstetrics and gynecology.
[127] T. Lehtimäki,et al. High‐dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial , 2005, Clinical pharmacology and therapeutics.
[128] V. Mootha,et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation , 2005, Neurology.
[129] G. López-Lluch,et al. Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells. , 2005, Biochimica et biophysica acta.
[130] K. Yazaki,et al. The AtPPT1 gene encoding 4-hydroxybenzoate polyprenyl diphosphate transferase in ubiquinone biosynthesis is required for embryo development in Arabidopsis thaliana , 2004, Plant Molecular Biology.
[131] S. Dimauro,et al. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. , 2004, Archives of neurology.
[132] I. Hargreaves. Ubiquinone: cholesterol's reclusive cousin , 2003, Annals of clinical biochemistry.
[133] T. Chojnacki,et al. Distribution and breakdown of labeled coenzyme Q10 in rat. , 2003, Free radical biology & medicine.
[134] Anil K. Goli,et al. Simvastatin‐induced lactic acidosis: A rare adverse reaction? , 2002, Clinical pharmacology and therapeutics.
[135] Joel S Perlmutter,et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. , 2002, Archives of neurology.
[136] S. Passi,et al. Lipophilic Antioxidants in Human Sebum and Aging , 2002, Free radical research.
[137] M. Kawamukai,et al. Dimer Formation of Octaprenyl-diphosphate Synthase (IspB) Is Essential for Chain Length Determination of Ubiquinone* , 2001, The Journal of Biological Chemistry.
[138] R. Floyd. Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[139] S. Browne,et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[140] B. Angelin,et al. Gemfibrozil‐induced decrease in serum ubiquinone and α‐ and γ‐tocopherol levels in men with combined hyperlipidaemia , 1998 .
[141] M. Beal,et al. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects , 1997, Annals of neurology.
[142] C. Clarke,et al. A C-methyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene , 1997, Journal of bacteriology.
[143] Y. Kamiya,et al. Polyprenyl diphosphate synthase essentially defines the length of the side chain of ubiquinone. , 1996, Biochimica et biophysica acta.
[144] R. E. Beyer. The role of ascorbate in antioxidant protection of biomembranes: Interaction with vitamin E and coenzyme Q , 1994, Journal of bioenergetics and biomembranes.
[145] I. Nonaka,et al. Muscle coenzyme Q10 in mitochondrial encephalomyopathies , 1991, Neuromuscular Disorders.
[146] B. Ames,et al. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[147] K. Kristensson,et al. Lipid Compositions of Different Regions of the Human Brain During Aging , 1990, Journal of neurochemistry.
[148] G. Dallner,et al. Age-related changes in the lipid compositions of rat and human tissues , 1989, Lipids.
[149] K. Folkers,et al. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[150] G. Cox,et al. Biosynthesis of Ubiquinone in Escherichia coli K-12: Biochemical and Genetic Characterization of a Mutant Unable to Convert Chorismate into 4-Hydroxybenzoate , 1974, Journal of bacteriology.
[151] P. Palacka,et al. Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. , 2022, Bratislavske lekarske listy.
[152] F. Rosenfeldt,et al. Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q10. , 2019, The Permanente journal.
[153] O. Gribouval,et al. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. , 2016, Journal of the American Society of Nephrology : JASN.
[154] Anne-Lise Ducluzeau,et al. Gene network reconstruction identifies the authentic trans-prenyl diphosphate synthase that makes the solanesyl moiety of ubiquinone-9 in Arabidopsis. , 2012, The Plant journal : for cell and molecular biology.
[155] C. Clarke,et al. The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesis. , 2009, Biochimica et biophysica acta.
[156] S. Heales,et al. The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10 , 2005, Drug safety.
[157] Kathleen Connell,et al. Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid‐soluble antioxidants , 2005, BioFactors.
[158] S. Dimauro,et al. Primary coenzyme Q10 deficiency and the brain , 2003, BioFactors.
[159] J. Bergemann,et al. Coenzyme Q10, a cutaneous antioxidant and energizer , 1999, BioFactors.
[160] F. L. Crane,et al. Isolation of a quinone from beef heart mitochondria. , 1957, Biochimica et biophysica acta.